Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma

American Journal of Pathology

Volumn 182, Issue 4, 2013, Pages 1092-1098

  Walther, Neele ^a,b   Ulrich, Antje ^a,b   Vockerodt, Martina ^a,c   Von Bonin, Frederike ^a   Klapper, Wolfram ^b,d   Meyer, Katharina ^b,e   Eberth, Sonja ^a,b   Pukrop, Tobias ^a,b   Spang, Rainer ^b,e   Trümper, Lorenz ^a,b   Kube, Dieter ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ENHANCER BINDING FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BURKITT LYMPHOMA; CANCER GROWTH; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; GERMINAL CENTER; HUMAN; HUMAN CELL; IN VITRO STUDY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA INTERFERENCE;

BURKITT LYMPHOMA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PALATINE TONSIL;

EID: 84875189534     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.12.013     Document Type: Article

References (30)

1. S.H. Swerdlow, E. Campo, and N.L. Harris WHO classification of tumours of haematopoietic and lymphoid tissues. Atlas of Hematologic Neoplasms ed 4 2008 IARC Press Lyon, France
2. R. Kuppers, and R. Dalla-Favera Mechanisms of chromosomal translocations in B cell lymphomas Oncogene 20 2001 5580 5594
3. M. Hummel, S. Bentink, H. Berger, W. Klapper, S. Wessendorf, T.F. Barth, H.W. Bernd, S.B. Cogliatti, J. Dierlamm, A.C. Feller, M.L. Hansmann, E. Haralambieva, L. Harder, D. Hasenclever, M. Kuhn, D. Lenze, P. Lichter, J.I. Martin-Subero, P. Moller, H.K. Muller-Hermelink, G. Ott, R.M. Parwaresch, C. Pott, A. Rosenwald, M. Rosolowski, C. Schwaenen, B. Sturzenhofecker, M. Szczepanowski, H. Trautmann, H.H. Wacker, R. Spang, M. Loeffler, L. Trumper, H. Stein, and R. Siebert A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling N Engl J Med 354 2006 2419 2430
4. E. Klein, and G. Klein Burkitt lymphoma Semin Cancer Biol 19 2009 345 346
5. A. Travis, A. Amsterdam, C. Belanger, and R. Grosschedl LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected] Genes Dev 5 1991 880 894
6. M.L. Waterman, W.H. Fischer, and K.A. Jones A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer Genes Dev 5 1991 656 669
7. F.J. Staal, and H.C. Clevers WNT signalling and haematopoiesis: a WNT-WNT situation Nat Rev Immunol 5 2005 21 30
8. F.J. Staal, T.C. Luis, and M.M. Tiemessen WNT signalling in the immune system: wNT is spreading its wings Nat Rev Immunol 8 2008 581 593
9. P.W. Derksen, E. Tjin, H.P. Meijer, M.D. Klok, H.D. MacGillavry, M.H. van Oers, H.M. Lokhorst, A.C. Bloem, H. Clevers, R. Nusse, R. van der Neut, M. Spaargaren, and S.T. Pals Illegitimate WNT signaling promotes proliferation of multiple myeloma cells Proc Natl Acad Sci U S A 101 2004 6122 6127
10. P. Gelebart, M. Anand, H. Armanious, A.C. Peters, J. Dien Bard, H.M. Amin, and R. Lai Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma Blood 112 2008 5171 5179
11. R.W. Groen, M.E. Oud, E.J. Schilder-Tol, M.B. Overdijk, D. ten Berge, R. Nusse, M. Spaargaren, and S.T. Pals Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies Cancer Res 68 2008 6969 6977
12. N.C. Gutierrez, E.M. Ocio, J. de Las Rivas, P. Maiso, M. Delgado, E. Ferminan, M.J. Arcos, M.L. Sanchez, J.M. Hernandez, and J.F. San Miguel Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals Leukemia 21 2007 541 549
13. H. Liang, Q. Chen, A.H. Coles, S.J. Anderson, G. Pihan, A. Bradley, R. Gerstein, R. Jurecic, and S.N. Jones Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue Cancer Cell 4 2003 349 360
14. D. Lu, Y. Zhao, R. Tawatao, H.B. Cottam, M. Sen, L.M. Leoni, T.J. Kipps, M. Corr, and D.A. Carson Activation of the Wnt signaling pathway in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 101 2004 3118 3123
15. C.G. Mullighan, S. Goorha, I. Radtke, C.B. Miller, E. Coustan-Smith, J.D. Dalton, K. Girtman, S. Mathew, J. Ma, S.B. Pounds, X. Su, C.H. Pui, M.V. Relling, W.E. Evans, S.A. Shurtleff, and J.R. Downing Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia Nature 446 2007 758 764
16. J. Roman-Gomez, L. Cordeu, X. Agirre, A. Jimenez-Velasco, E. San Jose-Eneriz, L. Garate, M.J. Calasanz, A. Heiniger, A. Torres, and F. Prosper Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia Blood 109 2007 3462 3469
17. A. Valencia, J. Roman-Gomez, J. Cervera, E. Such, E. Barragan, P. Bolufer, F. Moscardo, G.F. Sanz, and M.A. Sanz Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia Leukemia 23 2009 1658 1666
18. A. Gutierrez Jr., R.C. Tschumper, X. Wu, T.D. Shanafelt, J. Eckel-Passow, P.M. Huddleston III, S.L. Slager, N.E. Kay, and D.F. Jelinek LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B cell lymphocytosis Blood 116 2010 2975 2983
19. D. Kube, U. Holtick, M. Vockerodt, T. Ahmadi, B. Haier, I. Behrmann, P.C. Heinrich, V. Diehl, and H. Tesch STAT3 is constitutively activated in Hodgkin cell lines Blood 98 2001 762 770
20. M. Vockerodt, B. Haier, P. Buttgereit, H. Tesch, and D. Kube The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway Virology 280 2001 183 198
21. M. Vockerodt, D. Pinkert, S. Smola-Hess, A. Michels, R.M. Ransohoff, H. Tesch, and D. Kube The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulation Int J Cancer 114 2005 598 605
22. U. Holtick, M. Vockerodt, D. Pinkert, N. Schoof, B. Sturzenhofecker, N. Kussebi, K. Lauber, S. Wesselborg, D. Loffler, F. Horn, L. Trumper, and D. Kube STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis Leukemia 19 2005 936 944
23. G.K. Smyth, J. Michaud, and H.S. Scott Use of within-array replicate spots for assessing differential expression in microarray experiments Bioinformatics 21 2005 2067 2075
24. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Statist Soc B 57 1995 289 300
25. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci U S A 102 2005 15545 15550
26. D.R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A.M. Chinnaiyan Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression Proc Natl Acad Sci U S A 101 2004 9309 9314
27. U. Klein, Y. Tu, G.A. Stolovitzky, J.L. Keller, J. Haddad Jr., V. Miljkovic, G. Cattoretti, A. Califano, and R. Dalla-Favera Transcriptional analysis of the B cell germinal center reaction Proc Natl Acad Sci U S A 100 2003 2639 2644
28. A. Schrader, S. Bentink, R. Spang, D. Lenze, M. Hummel, M. Kuo, J.R. Arrand, P.G. Murray, L. Trümper, D. Kube, and M. Vockerodt High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas Int J Cancer 131 2012 E348 E361
29. E. Cubedo, A.J. Gentles, C. Huang, Y. Natkunam, S. Bhatt, X. Lu, X. Jiang, I. Romero-Camarero, A. Freud, S. Zhao, C.E. Bacchi, J.A. Martinez-Climent, I. Sanchez-Garcia, A. Melnick, and I.S. Lossos Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma Blood 119 2012 5478 5491
30. R.K. Gandhirajan, P.A. Staib, K. Minke, I. Gehrke, G. Plickert, A. Schlosser, E.K. Schmitt, M. Hallek, and K.A. Kreuzer Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo Neoplasia 12 2010 326 335